Wave Life Sciences (WVE) Net Margin (QoQ) (2015 - 2026)

Wave Life Sciences (WVE) Net Margin (QoQ) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Wave Life Sciences 1.05 Bn 677.62 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 -298,439.00
Jun 30, 2025 -6,924.00
Jun 30, 2024 8,451.00
Mar 31, 2024 -19,567.00
Dec 31, 2023 -7,076.00
Sep 30, 2023 11,020.00
Jun 30, 2023 11,650.00
Mar 31, 2023 331,580.00
Dec 31, 2022 1.02 Mn
Sep 30, 2022 -267,335.00
Jun 30, 2022 -885,147.00
Mar 31, 2022 -18,975.00
Dec 31, 2021 -195,394.00
Sep 30, 2021 137,937.00
Dec 31, 2020 65,442.00
Sep 30, 2020 37,946.00
Jun 30, 2020 -19,750.00
Mar 31, 2020 122,403.00
Dec 31, 2019 -63,356.00
Sep 30, 2019 -118,201.00